Physical Pharmaceutics I (BP302T) Overview
Course: B.Pharm Semester III (PCI CBCS)
Subject Code: BP302T (Theory) / BP306P (Practical)
Focus Area: Physical Chemistry Principles in Drug Formulation
Searching for verified BP302T Physical Pharmaceutics 1 notes PDF and solved numerical derivation manuals? Physical Pharmaceutics I (BP302T) applies fundamental physicochemical laws to modern drug development, governing solubility enhancement, phase transitions, interfacial surface phenomena, complexation, and biological buffer systems.
Study Physical Pharmaceutics I (BP302T) Online
Interactive phase diagrams, surface tension formulas, and buffer equations on Pharmacist365.
1. Unit-by-Unit PCI Curriculum Summary
- Unit 1: Solubility of Drugs: Solubility expressions, mechanisms of solute-solvent interactions, ideal and real solutions, Raoult's law, solubility of gases in liquids (Henry's law), solubility of liquids in liquids (partially miscible liquids, CST), distribution law (Nernst distribution law and applications), and modern solubility enhancement techniques (cosolvency, complexation, micronization, solid dispersions).
- Unit 2: States of Matter & Phase Rule: Gaseous state, liquid state, solid state (polymorphism, amorphous vs crystalline solids, solvates, hydrates), liquid crystals, glass transition temperature, and Gibbs Phase Rule with one-component (water, sulphur) and two-component systems.
- Unit 3: Surface and Interfacial Phenomena: Liquid interfaces, surface and interfacial tension, measurement methods (Capillary Rise, Drop Weight, Du Nouy Ring Tensiometer), adsorption at liquid interfaces, surface active agents, Griffin's HLB scale, critical micelle concentration (CMC), and solubilization.
- Unit 4: Complexation and Protein Binding: Classification of complexes (metal complexes, organic molecular complexes, inclusion complexes with cyclodextrins), methods of analysis (continuous variation, pH titration, distribution method), and clinical significance of drug-protein binding.
- Unit 5: pH, Buffers & Isotonic Solutions: Sorensen's pH scale, Henderson-Hasselbalch equation and buffer capacity, pharmaceutical buffers (Clark-Lubs, Sorensen's phosphate buffer), biological buffer systems, and methods of adjusting tonicity (Cryoscopic, Sodium chloride equivalent method).
2. University Exam High-Yield Questions
Short & Numerical Questions (2 & 5 Marks)
- Define Critical Micelle Concentration (CMC) and mention factors affecting it.
- Derive Henderson-Hasselbalch equation for weak acidic buffers.
- Differentiate between crystalline and amorphous forms with pharmaceutical significance.
- Explain Nernst Distribution Law and its limitations.
- Calculate the amount of NaCl required to make a 1% solution of drug isotonic with blood (Cryoscopic method).
Long Descriptive Essays (10 Marks)
- Describe the methods used for determination of surface and interfacial tension with working principles and diagrams (Du Nouy Ring & Drop Weight method).
- Explain the various mechanisms and techniques used for enhancing the solubility of poorly water-soluble drugs.
- Classify complexes with suitable examples. Discuss cyclodextrin inclusion complexes and their pharmaceutical applications.
3. Recommended Standard Textbooks
- Martin's Physical Pharmacy and Pharmaceutical Sciences by Patrick J. Sinko (Lippincott Williams & Wilkins).
- Physical Pharmacy by Alfred Martin, James Swarbrick, and Arthur Cammarata.
- Tutorial Pharmacy by J.W. Cooper and Colin Gunn.
4. Frequently Asked Questions (FAQ)
What is the HLB value required for O/W and W/O emulsions?
Surfactants with an HLB value of 3 to 6 are lipophilic and produce Water-in-Oil (W/O) emulsions, while surfactants with an HLB value of 8 to 16 are hydrophilic and produce Oil-in-Water (O/W) emulsions.
Why is protein binding important in pharmacokinetics?
Only the unbound (free) drug fraction can cross biological membranes, reach receptor targets, exert pharmacological actions, and undergo hepatic metabolism and renal excretion. Highly bound drugs have longer half-lives and potential for displacement drug interactions.